Found: 67
Select item for more details and to access through your institution.
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gastrointestinal Tract: A Case Series.
- Published in:
- Healthcare (2227-9032), 2022, v. 10, n. 4, p. 708, doi. 10.3390/healthcare10040708
- By:
- Publication type:
- Article
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 7, p. 541, doi. 10.1007/s40261-024-01372-0
- By:
- Publication type:
- Article
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 354, doi. 10.1016/j.clcc.2021.07.005
- By:
- Publication type:
- Article
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
C. spinosa L. subsp. rupestris Phytochemical Profile and Effect on Oxidative Stress in Normal and Cancer Cells.
- Published in:
- Molecules, 2022, v. 27, n. 19, p. 6488, doi. 10.3390/molecules27196488
- By:
- Publication type:
- Article
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e245635, doi. 10.1001/jamanetworkopen.2024.5635
- By:
- Publication type:
- Article
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 820, doi. 10.3390/ijms23020820
- By:
- Publication type:
- Article
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data.
- Published in:
- Liver International, 2023, v. 43, n. 8, p. 1803, doi. 10.1111/liv.15641
- By:
- Publication type:
- Article
Phytochemical profiling, antibacterial and antioxidant properties of Crocus sativus flower: A comparison between tepals and stigmas.
- Published in:
- Open Chemistry, 2022, v. 20, n. 1, p. 431, doi. 10.1515/chem-2022-0155
- By:
- Publication type:
- Article
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221096878
- By:
- Publication type:
- Article
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02332-2
- By:
- Publication type:
- Article
Differential diagnosis: retroperitoneal fibrosis and oncological diseases.
- Published in:
- Open Medicine, 2020, v. 15, n. 1, p. 22, doi. 10.1515/med-2020-0005
- By:
- Publication type:
- Article
Cancer- and non-cancer related chronic pain: from the physiopathological basics to management.
- Published in:
- Open Medicine, 2019, v. 14, n. 1, p. 761, doi. 10.1515/med-2019-0088
- By:
- Publication type:
- Article
Use of rituximab in NHL malt type pregnant in I° trimester for two times.
- Published in:
- Open Medicine, 2019, v. 14, n. 1, p. 757, doi. 10.1515/med-2019-0087
- By:
- Publication type:
- Article
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-020-01811-8
- By:
- Publication type:
- Article
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the COVID-19 Pandemic.
- Published in:
- Oncologist, 2022, v. 27, n. 8, p. e633, doi. 10.1093/oncolo/oyac071
- By:
- Publication type:
- Article
HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1395, doi. 10.1634/theoncologist.2018-0785
- By:
- Publication type:
- Article
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 185, doi. 10.1634/theoncologist.2018-0072
- By:
- Publication type:
- Article
Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1178, doi. 10.1634/theoncologist.2017-0573
- By:
- Publication type:
- Article
The Combination of Mild Salinity Conditions and Exogenously Applied Phenolics Modulates Functional Traits in Lettuce.
- Published in:
- Plants (2223-7747), 2021, v. 10, n. 7, p. 1457, doi. 10.3390/plants10071457
- By:
- Publication type:
- Article
Case report of unusual synchronous anal and rectal squamous cell carcinoma: clinical and therapeutic lesson.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1187623
- By:
- Publication type:
- Article
Valorisation of Crocus sativus flower parts for herbal infusions: impact of brewing conditions on phenolic profiling, antioxidant capacity and sensory traits.
- Published in:
- International Journal of Food Science & Technology, 2022, v. 57, n. 6, p. 3838, doi. 10.1111/ijfs.15713
- By:
- Publication type:
- Article
Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028841
- By:
- Publication type:
- Article
Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 51, doi. 10.1177/1758834012462462
- By:
- Publication type:
- Article
Targeting EphA2 and DDR signaling can overcome the BRAF and MEK inhibitors acquired resistance in melanoma cell lines.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-022-00133-5
- By:
- Publication type:
- Article
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 3, p. 1666, doi. 10.1002/ehf2.13879
- By:
- Publication type:
- Article
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-72711-2
- By:
- Publication type:
- Article
Development of a supramolecular solvent–based extraction method for application to quantitative analyses of a wide range of organic contaminants in indoor dust.
- Published in:
- Analytical & Bioanalytical Chemistry, 2024, v. 416, n. 22, p. 4973, doi. 10.1007/s00216-024-05433-3
- By:
- Publication type:
- Article
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 809, doi. 10.3390/biomedicines12040809
- By:
- Publication type:
- Article
Beyond N staging in colorectal cancer: Current approaches and future perspectives.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.937114
- By:
- Publication type:
- Article
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS / BRAF Wild-Type mCRC Patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.940523
- By:
- Publication type:
- Article
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2117, doi. 10.3390/cancers15072117
- By:
- Publication type:
- Article
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13 , 1941.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133053
- By:
- Publication type:
- Article
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092204
- By:
- Publication type:
- Article
Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5715, doi. 10.3390/cancers13225715
- By:
- Publication type:
- Article
How Immunotherapy Has Changed the Continuum of Care in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4719, doi. 10.3390/cancers13184719
- By:
- Publication type:
- Article
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1941, doi. 10.3390/cancers13081941
- By:
- Publication type:
- Article
Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 859, doi. 10.3390/cancers11060859
- By:
- Publication type:
- Article
An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program.
- Published in:
- International Journal of Environmental Research & Public Health, 2020, v. 17, n. 6, p. 0, doi. 10.3390/ijerph17061929
- By:
- Publication type:
- Article
User‐generated content in the era of digital well‐being: A netnographic analysis in a healthcare marketing context.
- Published in:
- Psychology & Marketing, 2020, v. 37, n. 4, p. 578, doi. 10.1002/mar.21327
- By:
- Publication type:
- Article
The Role of Dual-Energy CT for the Assessment of Liver Metastasis Response to Treatment: Above the RECIST 1.1 Criteria.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 879, doi. 10.3390/jcm12030879
- By:
- Publication type:
- Article
Endorectal Ultrasound and Magnetic Resonance Imaging for Rectal Cancer Staging: A Modern Multimodality Approach.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 641, doi. 10.3390/jcm10040641
- By:
- Publication type:
- Article
Bee Products: A Representation of Biodiversity, Sustainability, and Health.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 9, p. 970, doi. 10.3390/life11090970
- By:
- Publication type:
- Article
Multi-Omic Approaches in Colorectal Cancer beyond Genomic Data.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020128
- By:
- Publication type:
- Article
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 8, p. 1520, doi. 10.1002/ijc.34632
- By:
- Publication type:
- Article
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 3, p. 473, doi. 10.1002/ijc.34033
- By:
- Publication type:
- Article